July 12, 2021

Monday, July 12, 2021

by Gist Healthcare


Listen Time: 06:00

President Biden signed a sweeping executive order aimed at increasing competition. Funding for digital health companies continues to break records. And the FDA chief calls for an investigation of the agency’s approval of Alzheimer’s drug Aduhelm.